Linezolid 400mg Oral Suspension from Canada
Linezolid 400mg/5mL oral suspension is a liquid antibiotic formulation for pediatric or dysphagic patients treating skin and soft tissue infections. Classified under HTS 3004.90.92.13 as it contains linezolid in measured doses for anti-infective therapeutic use, suitable for retail sale.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide child-resistant closure certification and shake-well labeling compliance for suspension formulations
• Include beyond-use dating and reconstitution instructions in import documentation
• Ensure cold chain validation if requiring refrigeration during transport